$INO Dr. Kim's words earlier this year on CNBC "I don't really care about the share price" ...What kind of CEO of a publicly traded company says that? No wonder Merck was happy to see him leave, this dope has an atrocious embarrassing business acumen and ZERO respect for shareholders. Inovio is a smoke and mirrors pharmaceutical company until they can demonstrate something tangible for investors.